Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies
- PMID: 11471017
Rapid detection of drug resistant HIV -1 to reverse transcriptase and protease inhibitors in HIV-infected patients receiving highly active antiretroviral therapies
Abstract
Objective: To develop and validate a rapid and sensitive method that can be used to detect emergence of HIV-1 drug resistant viruses in HIV-infected patients receiving highly active antiretroviral therapies (HAART).
Methods: HIV-1 viral RNA was extracted from plasma and amplified by nested RT-PCR. Nucleotide sequences of the reverse transcriptase (RT) and protease (PR) genes were determined by automated DNA sequencing.
Results: RT and PR sequences can be reliably determined with a minimum 2,000 copies/ml of viral RNA in plasma. Emergence of drug resistant viruses can he detected as soon as it reached to > 25% of the total viral populations. By using this method, drug-resistant viral populations were found to correlate with rebound of viral RNA level after prolonged antiretroviral therapies in HIV-infected children.
Conclusions: This rapid and sensitive HIV-1 genotyping method can be used to predict and confirm emergence of HIV-1 drug resistance in HIV-infected patients receiving HAART.
Similar articles
-
In vivo emergence of drug-resistant mutations at less than 50 HIV-1 RNA copies/mL that are maintained at viral rebound in longitudinal plasma samples from human immunodeficiency virus type-1-infected patients on highly active antiretroviral therapy.J Hum Virol. 2001 Nov-Dec;4(6):317-28. J Hum Virol. 2001. PMID: 12082398
-
A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.J Virol Methods. 2006 May;133(2):137-45. doi: 10.1016/j.jviromet.2005.11.004. Epub 2005 Dec 20. J Virol Methods. 2006. PMID: 16375980
-
Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.J Clin Virol. 2005 Jul;33(3):224-9. doi: 10.1016/j.jcv.2004.06.014. Epub 2005 Jan 12. J Clin Virol. 2005. PMID: 15911444
-
Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.AIDS Rev. 2003 Jan-Mar;5(1):25-35. AIDS Rev. 2003. PMID: 12875105 Review.
-
Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S58-61. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 8595511 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials